← Back to news

Markets

The Sky Is The Limit For The Current Oil Price Rally

Y

The Small-Cap Value ETF Built on 50 Years of Academic Research Is Beating The S&P 500 Now

Y

Rumble shares slide on fourth quarter earnings miss

Y

Robinhood’s new $695 Platinum card vs. $895 Amex Platinum: Which one has better perks?

Y

Alibaba Could Be the Sleeper AI Winner in 2026

Y

Two Overseas And Under The Radar Aerospace Stocks Pass Buy Points

Y

Do Private Jobs Data Complement or Contradict Official Statistics?

Y

Cinnaholic redeploys Square systems across franchise network

Y

Dubai Orders Crypto Exchange KuCoin to Stop Offering Services to Residents

Y

Why Is Barrick Mining Stock Sinking This Week?

Y

How to Make Your Retirement Savings Last Against Inflation

Y

Oil Is Surging and These 3 Energy Stocks Could Double Your Money Before 2027

Y

Costco (COST) Earnings Scorecard

Y

Warren Buffett Recommends This 1 Investment to All Investors. Here's How It Could Help Build a Million-Dollar Portfolio.

Y

Asphalt Paving Stock Hits A Road Bump

Y

Google Grabs Attention, But Funds Go Crazy For This 'Pick-And-Shovel' AI Stock

Y

Six Flags Sells Some Parks to EPR: Who Wins?

Y

Dentsply Sirona (XRAY) Added by Ariel Fund as Strategic Reset Targets Long-Term Growth

Y

Gap shares fall on earnings miss despite continued sales growth

Y

Equinor and Wellesley launch joint NCS exploration project

Y

A shocking percentage of people earning more than $300,000 live paycheck to paycheck. Why these wealthy people burn through cash.

Y

Sphere Entertainment Co. (SPHR) Rallies on Strong Demand for The Wizard of Oz at Las Vegas Sphere

Y

Nike Could Be One Step Closer to Converse Sale as Swoosh Reveals $300 Million in Restructuring Costs

Y

IDEAYA Biosciences, Inc. (IDYA) Enrolls First Patient in Phase 1 Trial of IDE034 Bispecific ADC

Y

Stifel Lowers Its Price Target on Eos Energy Enterprises, Inc. (EOSE) to Maintains a Buy Rating

Y

H.C. Wainwright Raises its Price Target on CG Oncology, Inc. (CGON) to $80 and Maintains a Buy Rating

Y

Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating

Y

Truist Raises Its Price Target on BridgeBio Pharma, Inc. (BBIO) to $95 and Maintains a Buy Rating

Y

H.C. Wainwright Lowered Its Price Target on SoundHound AI, Inc. (SOUN) to $20 and Maintains a Buy Rating

Y

Truist Raises Its Price Target on CoreWeave, Inc. (CRWV) to $85 and Maintains a Hold Rating

Y

Guggenheim Raises Its Price Target on Arcutis Biotherapeutics, Inc. (ARQT) to $35 and Maintains a Buy Rating

Y

RBC Capital Lowers Its Price Target on Viridian Therapeutics, Inc. (VRDN) to $42 and Maintains an Outperform Rating

Y

H.C. Wainwright Raised Its Price Target on ImmunityBio, Inc. (IBRX) to $15 from $10 and Maintains a Buy Rating

Y

Petrobras 2025 net income jumps 160% to $19.6bn

Y

Dow tumbles and gas prices jump as war and weak jobs report rattle market

Y

Sasol downgraded to Neutral from Buy at UBS

Y

Integer Holdings Corp (ITGR) Was Down 40% YOY Despite Strong Market Position and a Competitive Moat

Y

I Asked ChatGPT for Specific Steps for Lowering My Tax Bill Before I File — Here’s What It Said

Y

The Tax Cost of Day Trading: What New Investors Don’t See Coming

Y

Kroger forecasts modest 2026 growth as leadership transition continues

Y

Marvell (MRVL) Did These Things Right to Send Shares 16% Higher Today

Y

Adobe Stock Jumps With Software Sector Ahead Of Key Earnings Report; 3 Gold Stocks To Watch

Y

Executive optimism on US economy rises in Q1 AICPA-CIMA survey

Y

Why D-Wave Quantum Stock Plummeted 11.5% Last Month and Has Traded Flat in March

Y

Warren Buffett called this the ‘secret sauce’ to his company’s success. How to use his strategy to grow your wealth

Y

Pipeline Gaps and Refinery Shifts Expose California’s Energy Vulnerability

Y

Here’s What’s Impacting Six Flags Entertainment Corporation (FUN)

Y

Crush the Stock Market in 2026 With These 3 Strategies — Hint: They’re Simpler Than You Think

Y

WEX (WEX) is Trading at a Deep Discount Despite Its Strengths

Y

Here's What Owlet's Disappointing Outlook Says For 2026

Y